The global market for cell culture is experiencing a massive overhaul. A prominent transition is evident in the market in terms of product differentiation and new consumable and instrument launches. The market has been gaining substantially from the rising application of cell culture technology in drug discovery, cancer diagnosis, and the production of biologics.
Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
Over the coming years, the increasing usage of cell culture in a number of applications, such as creating model systems for research, stem cell research, genetic engineering, and the study of cellular structures and functions are likely to boost this market substantially over the next few years. Apart from this, the rising investment by life sciences companies for research, development, and innovation in stem cells and the extensive industry and academic collaborations are also expected to drive the market’s growth in the near future.
The opportunity in the global market for cell culture, which stood at US$6.09 bn in 2013, is anticipated to proliferate at a CAGR of 7.10% over the period from 2014 to 2022 and attain a value of US$11.31 bn by the end of the forecast period.
Massive Investments Driving Cell Culture Market
Numerous sectors such as research, bioprocessing and manufacturing, academics, and regenerative medicines use cell culture, which has led to a growing demand for these products. As a result, leading pharmaceutical companies are now focusing on increasing their capabilities into biopharmaceutical manufacturing by entering into alliances with biotech companies. For instance, Thermo Fisher Scientific acquired Life Technologies in February 2014 to establish a stronghold over the cell culture market.
Massive capital investments and specificity of each bio-manufacturing process is leading to a shift toward contract manufacturing and research. Furthermore, the expanding scope of cell culture in areas such as stem cell research is also proving to be a positive influence on the market.
Artificial organs are engineered biological substitutes used to replace the structure and restore the functions of an impaired or diseased organ. The market for artificial organs is projected to expand at a double-digit CAGR during the forecast period. Moreover, the trend toward serum-free, specialty and customized media solutions is expected to boost market growth and the applicability of cell culture technology.
Demand for Advanced Manufacturing Capabilities to Fulfill Requirements
The process of cell culture is complex and requires monitoring several parameters such as temperature, humidity, nutrients, and toxins. Any deviation from the precise handling technique could have an impact on the efficacy of the end product. These constraints are expected to bottleneck the process of cell culture development and manufacturing.
Moreover, the growth of the cell culture market is also likely to be affected by the development of alternative technologies such as transgenic animals and plants for biopharmaceutical production. Ethical concerns over the use of animal sources is another aspect that may curtail the cell culture market growth.